Glycocheck - Syndrom X Studies
Post Count: 3
![capillary rarefication in long COVID syndrome](https://d2wvkdujf82siv.cloudfront.net/wp-content/uploads/2022/08/covid-syndrome-1024x603.jpg)
August 11, 2022
Persistent capillary rarefication in long COVID syndrome
Recent studies have highlighted Coronavirus disease 2019 (COVID-19) as a multisystemic vascular disease. Up to 60% of the patients suffer from long-term sequelae and persistent symptoms even 6 months after the initial infection.
![Glycocalyx Damage in COVID-19](https://d2wvkdujf82siv.cloudfront.net/wp-content/uploads/2020/12/glycocalyx-damage-1024x603.jpg)
December 31, 2020
Vascular Endothelial Glycocalyx Damage in COVID-19
The new coronavirus disease-2019 (COVID-19), which is spreading around the world and threatening people, is easily infecting a large number of people through airborne droplets; moreover, patients with hypertension, diabetes, obesity, and cardiovascular disease are more likely to experience severe conditions.
![sublingual microvascular glycocalyx](https://d2wvkdujf82siv.cloudfront.net/wp-content/uploads/2018/02/sublingual-microvascular-1024x603.jpg)
February 14, 2018
Bedside analysis of the sublingual microvascular glycocalyx in the emergency room and intensive care unit – the GlycoNurse study.
Deterioration of the endothelial glycocalyx (eGC), a protective carbohydrate-rich layer lining the luminal surface of the endothelium, plays a key role in vascular barrier dysfunction and eventually organ-failure in systemic inflammatory response syndrome and sepsis.